Site Search
Google Search
search button

Breaking News:

Clinton Believes Trump Will 'Wholesale Fire People' After Midterms      - | -     Andrew McCabe the Next Person to Write Trump Administration Tell-All Book      - | -     Kavanaugh Accuser Wants an FBI Investigation Before Senate Hearing      - | -     Legal Experts Believe Mueller Set Up Manafort's Plea Deal So He Couldn't Be Pardoned      - | -     Trump Not Happy With Florida GOP Governor Candidate Ron DeSantis     - | -     Bill And Melinda Gates Warn Decades Of Progress At Risk     - | -     GOP Congressman Invokes 'The Deep State'
CRISPR Study Sends Biotech Stocks Tumbling
Get Business & Technology Alerts

viewsViews 827
10 Jan 2018 06:09 AM EST

On Monday, a new paper had identified a possible barrier to using the revolutionary gene-editing tool CRISPR in humans. The news sent the stocks of all three major CRISPR biotech firms tumbling in premarket trading. They declined by as much as 11.9 percent.
In recent years, CRISPR has been credited with the potential power to correct any number of devastating diseases. Researchers have used it to cure mice of deadly genetic conditions like hemophilia B, Lou Gehrig’s disease, and Huntington’s disease. In the U.S., the first human CRISPR trials are slated to begin this year.

Post Your Comment
Excellent Very Good Good Fair Poor



Recently Posted Comments
FREE
AllMediaNY AllMediaNY AllMedaiNY